Production (Stage)
Medtronic plc
MDT
$89.92
$0.520.58%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 04/25/2025 | 01/24/2025 | 10/25/2024 | 07/26/2024 | 04/26/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.54B | 33.20B | 33.00B | 32.58B | 32.36B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.54B | 33.20B | 33.00B | 32.58B | 32.36B |
| Cost of Revenue | 11.61B | 11.42B | 11.42B | 11.23B | 11.09B |
| Gross Profit | 21.93B | 21.78B | 21.58B | 21.35B | 21.27B |
| SG&A Expenses | 10.75B | 10.57B | 10.50B | 10.40B | 10.34B |
| Depreciation & Amortization | 1.81B | 1.66B | 1.67B | 1.68B | 1.69B |
| Other Operating Expenses | 230.00M | 89.00M | 227.00M | 232.00M | 179.00M |
| Total Operating Expenses | 27.12B | 26.47B | 26.56B | 26.28B | 26.04B |
| Operating Income | 6.42B | 6.73B | 6.44B | 6.29B | 6.33B |
| Income Before Tax | 5.63B | 5.22B | 5.16B | 4.91B | 4.84B |
| Income Tax Expenses | 937.00M | 935.00M | 833.00M | 954.00M | 1.13B |
| Earnings from Continuing Operations | 4.69K | 4.29K | 4.32K | 3.96K | 3.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.00M | -29.00M | -35.00M | -28.00M | -28.00M |
| Net Income | 4.66B | 4.26B | 4.29B | 3.93B | 3.68B |
| EBIT | 6.42B | 6.73B | 6.44B | 6.29B | 6.33B |
| EBITDA | 9.13B | 9.40B | 9.08B | 8.93B | 8.97B |
| EPS Basic | 3.63 | 3.30 | 3.28 | 2.98 | 2.77 |
| Normalized Basic EPS | 3.13 | 3.06 | 3.01 | 2.97 | 2.98 |
| EPS Diluted | 3.62 | 3.29 | 3.27 | 2.96 | 2.75 |
| Normalized Diluted EPS | 3.12 | 3.05 | 3.00 | 2.97 | 2.98 |
| Average Basic Shares Outstanding | 5.14B | 5.18B | 5.23B | 5.28B | 5.31B |
| Average Diluted Shares Outstanding | 5.16B | 5.20B | 5.24B | 5.29B | 5.32B |
| Dividend Per Share | 2.80 | 2.79 | 2.78 | 2.77 | 2.76 |
| Payout Ratio | 76.98% | 84.62% | 84.54% | 92.84% | 99.73% |